AAAAAA

   
Results: 1-8 |
Results: 8
Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart
Authors: Brodde, OE Bruck, H Leineweber, K Seyfarth, T
Citation: Oe. Brodde et al., Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart, BAS R CARD, 96(6), 2001, pp. 528-538
Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: involvement of only alpha(1A)-adrenoceptors
Authors: Ponicke, K Schluter, KD Heinroth-Hoffmann, I Seyfarth, T Goldberg, M Osten, B Piper, HM Brodde, OE
Citation: K. Ponicke et al., Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: involvement of only alpha(1A)-adrenoceptors, N-S ARCH PH, 364(5), 2001, pp. 444-453
Analysis of cardiac energy metabolism in valve disease using P-31-MR-spectroscopy
Authors: Beer, M Viehrig, M Seyfarth, T Sandstede, J Lipke, C Pabst, T Kenn, W Harre, K Horn, M Landschutz, W von Kienlin, M Neubauer, S Hahn, D
Citation: M. Beer et al., Analysis of cardiac energy metabolism in valve disease using P-31-MR-spectroscopy, RADIOLOGE, 40(2), 2000, pp. 162-167
The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats
Authors: Seyfarth, T Gerbershagen, HP Giessler, C Leineweber, K Heinroth-Hoffmann, I Ponicke, K Brodde, OE
Citation: T. Seyfarth et al., The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats, J MOL CEL C, 32(12), 2000, pp. 2315-2326
Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats
Authors: Leineweber, K Seyfarth, T Brodde, OE
Citation: K. Leineweber et al., Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats, BR J PHARM, 131(7), 2000, pp. 1438-1444
Determination of absolute concentrations of cardiac high-energy phosphatesusing P-31-MR-spectroscopy and SLOOP in healthy and diseased myocardium.
Authors: Beer, M Landschutz, W Meininger, M Seyfarth, T Viehrig, M Sandstede, J Pabst, T Kenn, W Horn, M Harre, K von Kienlin, M Neubauer, S Hahn, D
Citation: M. Beer et al., Determination of absolute concentrations of cardiac high-energy phosphatesusing P-31-MR-spectroscopy and SLOOP in healthy and diseased myocardium., ROFO-F RONT, 171(1), 1999, pp. 65-68
Concentrations of human cardiac phosphorus metabolites determined by SLOOPP-31 NMR spectroscopy
Authors: Meininger, M Landschutz, W Beer, M Seyfarth, T Horn, V Pabst, T Haase, A Hahn, D Neubauer, S von Kienlin, M
Citation: M. Meininger et al., Concentrations of human cardiac phosphorus metabolites determined by SLOOPP-31 NMR spectroscopy, MAGN RES M, 41(4), 1999, pp. 657-663
New N-1-hetarylmethylene-substituted amidrazones with potential antimycobacterial activity
Authors: Ranft, D Seyfarth, T Schaper, KJ Lehwark-Yvetot, G Bruhn, C Buge, A
Citation: D. Ranft et al., New N-1-hetarylmethylene-substituted amidrazones with potential antimycobacterial activity, ARCH PHARM, 332(12), 1999, pp. 427-430
Risultati: 1-8 |